Detalhe da pesquisa
1.
Food Intake and Eating Behavior After Bariatric Surgery.
Physiol Rev;
98(3): 1113-1141, 2018 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29717927
2.
Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial.
Lancet;
2024 May 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38782004
3.
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet;
402(10402): 613-626, 2023 08 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37385275
4.
Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities.
Int J Obes (Lond);
2024 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38454010
5.
The emergence of obesity in type 1 diabetes.
Int J Obes (Lond);
48(3): 289-301, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38092958
6.
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.
Cardiovasc Diabetol;
23(1): 63, 2024 02 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38341541
7.
Hypothalamic control of body fat mass by food intake: The key to understanding why obesity should be treated as a disease.
Diabetes Obes Metab;
26 Suppl 2: 3-12, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38351898
8.
Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population.
Diabetes Obes Metab;
2024 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38783825
9.
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis.
Gut;
72(2): 392-403, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35820779
10.
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.
Lancet;
399(10322): 394-405, 2022 01 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34600604
11.
Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial.
Int J Obes (Lond);
47(11): 1132-1142, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37696925
12.
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison.
Diabetes Obes Metab;
25(9): 2626-2633, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37344384
13.
Impact of Bariatric Surgery on Subtilisin/Kexin Type 9 (PCSK9) Gene Expression and Inflammation in the Adipose Tissue of Obese Diabetic Rats.
Int J Mol Sci;
24(23)2023 11 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38069302
14.
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lancet;
398(10317): 2160-2172, 2021 12 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34798060
15.
Oromotor and somatic taste reactivity during sucrose meals reveals internal state and stimulus palatability after gastric bypass in rats.
Am J Physiol Regul Integr Comp Physiol;
322(3): R204-R218, 2022 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35043683
16.
Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society.
Am J Kidney Dis;
80(6): 783-793, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36280397
17.
Food Intake Following Gastric Bypass Surgery: Patients Eat Less but Do Not Eat Differently.
J Nutr;
152(11): 2319-2332, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36774099
18.
Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats.
Clin Sci (Lond);
136(21): 1485-1511, 2022 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36259366
19.
Consensus report: Definition and interpretation of remission in type 2 diabetes.
Diabet Med;
39(3): e14669, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34460965
20.
CRABP2 - A novel biomarker for high-risk endometrial cancer.
Gynecol Oncol;
167(2): 314-322, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36163055